PP_1170x120_10-25-21

Phil Rackliffe

Walgreens, Kaléo expand pharmacy program

Walgreens, Kaléo expand pharmacy program

DEERFIELD, Ill. — Walgreens and Kaléo announced Thursday AUVI-q (epinephrine injection, USP) 0.1 mg auto-injector is available at Walgreens locations nationwide. AUVI-q 0.1 mg is the first and only epinephrine auto-injector (EAI) approved by the U.S. Food and Drug Administration (FDA) for infants and toddlers weighing 16.5 to 33 pounds (7.5 to 15 kilograms). Through

Walgreens and kaléo team to address epinephrine auto-injector supply issues

Walgreens and kaléo team to address epinephrine auto-injector supply issues

DEERFIELD, Ill. and RICHMOND, Va. — Walgreens and kaléo, a privately-held pharmaceutical company, are working together to improve access to epinephrine auto-injectors by making kaléo’s AUVI-Q 0.15 mg and 0.3 mg available through Walgreens locations nationwide. This comes in an effort to help thousands of Americans with their epinephrine needs during the back to school